1, China Biotechnology Group Corporation
China Biotechnology Group Corporation was founded in 1989 (formerly known as China National Biological Products Corporation, in August 2003, the current name, hereinafter referred to as China Biotechnology Group), was originally the State-owned Assets Supervision and Administration Commission of the State Council for the management of the state-owned important backbone enterprises.
China Scientific Instruments Import & Export Corporation (CSIEC) and China Medical & Healthcare Import & Export Corporation (CMHIEC), both of which belong to CSPG, have a wide range of customers and a mature sales network at home and abroad, and have a long history and high reputation in China's science and technology and healthcare fields.
2, Zhifei biological
Chongqing Zhifei Biological Products Company Limited, is a company engaged in the marketing of biological products. The company distributes Group A + C Meningococcal Polysaccharide Conjugate Vaccine, Group A + C + Y + W135 Meningococcal Polysaccharide Vaccine, Haemophilus influenzae type b Conjugate Vaccine, Lyophilized Hepatitis A Vaccine, Microcard, etc. (Some of the above products are exclusively produced and marketed in the country with no domestic competition from the same products), and its marketing network covers 31 provinces/autonomous regions/municipalities directly under the Central Government, as well as cities and municipalities across the country.
3. Beijing Tiantan Biological Products Co., Ltd
Beijing Tiantan Biological Products Co., Ltd is an enterprise engaged in the research, production and operation of vaccines, blood preparations, diagnostic supplies and other biological products, which was founded in 1998 by the Beijing Biological Products Research Institute (the predecessor of which was the Central Epidemiological Prevention Office of the Peking Government established in 1919).
4, Liaoning Chengda Biological Company Limited
Liaoning Chengda Biological Company Limited ("Chengda Biological") was established in June 2002 in Shenyang. The company adheres to the concept of "facing life, only responsibility" and the core values of "integrity and responsibility".
Dedicated to the research, development, production and promotion of biological products of "international level and domestic leading", the company has established itself as a highly respected and influential enterprise in the industry, with a production capacity of more than 40 million doses of human rabies vaccine and more than 10 million doses of inactivated human encephalitis B vaccine.
5, Kangtai biological
Shenzhen Kangtai Biological Products Co., Ltd. was founded in August 1988, is one of the high-tech enterprises in Shenzhen, mainly engaged in the research and development, production and sales of biological products. 2008, Kangtai Biological strategic capital reorganization, the registered capital of 357 million yuan.
In October 1987, the State Planning Commission approved the introduction of industrial production technology of genetically engineered recombinant (yeast) hepatitis B vaccine by the Ministry of Health, which was constructed in Beijing and Shenzhen.
On March 18, 2020, Kangtai Biological Products was ranked 14th in the "2020 Hurun China's 100 Strongest Healthy Private Enterprises" with a market capitalization of RMB 72 billion yuan.
Baidu Wikipedia-Kangtai Biologicals
Baidu Wikipedia-Liaoning Chengda Biologicals Co Ltd
Baidu Wikipedia-Beijing Tiantan Biological Products Co Ltd
Baidu Wikipedia-Zhi Fei Biologicals
Baidu Wikipedia-Chinese Biotechnology Co Ltd